|
Code
|
1317C
|
|
MA number
|
EU/1/16/1124/004
|
|
Product Form:
|
sol inj 1x0,6 ml/15 mg (pero napl.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Nordic Group B.V., Netherland
|
|
Therapeutic Class:
|
29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
|
|
ATC:
|
| L |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
| L04 |
Immunosuppressants |
| L04A |
Immunosuppressants |
| L04AX |
Other immunosuppressants |
| L04AX03 |
Methotrexate |
|
|
Shelf life:
|
24 |
|
Container:
|
pre-filled pen
|
|
Route of admin.:
|
Subcutaneous use
|
European Medicines Agency's database
